MRNA stability alterations mediated by HuR are necessary to sustain the fast growth of glioma cells

Journal of Neuro-Oncology

Volumn 106, Issue 3, 2012, Pages 531-542

  Bolognani, Federico ^a   Gallani, Anne Isabelle ^b   Sokol, Lena ^b   Baskin, David S ^a   Meisner Kober, Nicole ^b  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Gliomas; HuR; mRNA stability; RNA binding protein; Tissue microarray

Indexed keywords

CYCLOOXYGENASE 2; HUR PROTEIN; MESSENGER RNA; MYC PROTEIN; VASCULOTROPIN;

3' UNTRANSLATED REGION; ADENYLATE URIDYLATE RICH ELEMENT; ARTICLE; BRAIN NUCLEUS; CANCER GRADING; CANCER GROWTH; CANCER INHIBITION; CANCER STAGING; CONTROLLED STUDY; CYTOSOL; DNA STRUCTURE; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RNA STABILITY; TISSUE MICROARRAY;

3' UNTRANSLATED REGIONS; BRAIN NEOPLASMS; CELL FRACTIONATION; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLOOXYGENASE 2; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HU PARANEOPLASTIC ENCEPHALOMYELITIS ANTIGENS; HUMANS; INDOLES; MALE; PROTEIN ARRAY ANALYSIS; RNA STABILITY; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84857044072     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-011-0707-1     Document Type: Article

References (49)

1. Legler JM, Gloeckler Ries LA, Smith MA et al (1999) Brain and other central nervous system cancers: recent trends in incidence and mortality. J Natl Cancer Inst 91:1382-1390 (Pubitemid 29399996)
2. Wrensch M, Minn Y, Chew T et al (2002) Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro Oncol 4:278-299
3. Rich JN, Bigner DD (2004) Development of novel targeted therapies in the treatment of malignant glioma. Nat Rev Drug Discov 3:430-446 (Pubitemid 38618125)
4. Holland EC (2000) Glioblastoma multiforme: the terminator. Proc Natl Acad Sci USA 97:6242-6244 (Pubitemid 30412695)
5. Moore MJ (2005) From birth to death: the complex lives of eukaryotic mRNAs. Science 309:1514-1518 (Pubitemid 41266467)
6. Wilusz CJ, Wormington M, Peltz SW (2001) The cap-to-tail guide to mRNA turnover. Nat Rev Mol Cell Biol 2:237-246 (Pubitemid 33676966)
7. Perrone-Bizzozero N, Bolognani F (2002) Role of HuD and other RNA-binding proteins in neural development and plasticity. J Neurosci Res 68:121-126 (Pubitemid 34275005)
8. Bolognani F, Perrone-Bizzozero NI (2008) RNA-protein interactions and control of mRNA stability in neurons. J Neurosci Res 86:481-489 (Pubitemid 351204460)
9. Ross J (1995) mRNA stability in mammalian cells. Microbiol Rev 59:423-450
10. Chen CY, Shyu AB (1995) AU-rich elements: characterization and importance in mRNA degradation. Trends Biochem Sci 20:465-470
11. Hinman MN, Lou H (2008) Diverse molecular functions of Hu proteins. Cell Mol Life Sci 65:3168-3181
12. Wang W, Fan J, Yang X et al (2002) AMP-activated kinase regulates cytoplasmic HuR. Mol Cell Biol 22:3425-3436 (Pubitemid 34453982)
13. Peng SS, Chen CY, Xu N, Shyu AB (1998) RNA stabilization by the AU-rich element binding protein, HuR, an ELAV protein. EMBO J 17:3461-3470 (Pubitemid 28279518)
14. Keene JD (2001) Ribonucleoprotein infrastructure regulating the flow of genetic information between the genome and the proteome. Proc Natl Acad Sci USA 98:7018-7024 (Pubitemid 32567896)
15. Dalmau J, Furneaux HM, Gralla RJ, Kris MG, Posner JB (1990) Detection of the anti-Hu antibody in the serum of patients with small cell lung cancer-a quantitative western blot analysis. Ann Neurol 27:544-552 (Pubitemid 20149976)
16. Nabors LB, Gillespie GY, Harkins L, King PH (2001) HuR, a RNA stability factor, is expressed in malignant brain tumors and binds to adenine- and uridine-rich elements within the 3′ untranslated regions of cytokine and angiogenic factor mRNAs. Cancer Res 61:2154-2161 (Pubitemid 32692041)
17. López de Silanes I, Fan J, Yang X et al (2003) Role of the RNAbinding protein HuR in colon carcinogenesis. Oncogene 22:7146-7154 (Pubitemid 37378547)
18. Erkinheimo TL, Lassus H, Sivula A et al (2003) Cytoplasmic HuR expression correlates with poor outcome and with cyclooxygenase 2 expression in serous ovarian carcinoma. Cancer Res 63:7591-7594 (Pubitemid 37466678)
19. Denkert C, Weichert W, Pest S et al (2004) Overexpression of the embryonic-lethal abnormal vision-like protein HuR in ovarian carcinoma is a prognostic factor and is associated with increased cyclooxygenase 2 expression. Cancer Res 64:189-195 (Pubitemid 38114097)
20. Denkert C, Weichert W, Winzer KJ et al (2004) Expression of the ELAV-like protein HuR is associated with higher tumor grade and increased cyclooxygenase-2 expression in human breast carcinoma. Clin Cancer Res 10:5580-5586 (Pubitemid 39100499)
21. Heinonen M, Bono P, Narko K et al (2005) Cytoplasmic HuR expression is a prognostic factor in invasive ductal breast carcinoma. Cancer Res 65:2157-2161 (Pubitemid 40490122)
22. Heinonen M, Fagerholm R, Aaltonen Ket al (2007) Prognostic role of HuR in hereditary breast cancer. Clin Cancer Res 13:6959-6963 (Pubitemid 350276875)
23. Mrena J, Wiksten JP, Thiel A et al (2005) Cyclooxygenase-2 is an independent prognostic factor in gastric cancer and its expression is regulated by the messenger RNA stability factor HuR. Clin Cancer Res 11:7362-7368 (Pubitemid 41507695)
24. Denkert C, Koch I, von Keyserlingk N et al (2006) Expression of the ELAV-like protein HuR in human colon cancer: association with tumor stage and cyclooxygenase-2. Mod Pathol 19:1261-1269 (Pubitemid 44268197)
25. Koljonen V, Böhling T, Haglund C, Ristimäki A (2008) Expression of HuR in Merkel cell carcinoma and in normal skin. J Cutan Pathol 35:10-14 (Pubitemid 350264552)
26. Niesporek S, Kristiansen G, Thoma A et al (2008) Expression of the ELAV-like protein HuR in human prostate carcinoma is an indicator of disease relapse an linked to COX-2 expression. Int J Oncol 32:341-347 (Pubitemid 351188300)
27. Sakuma T, Nakagawa T, Ido K, Takeuchi H, Sato K, Kubota T (2008) Expression of vascular endothelial growth factor-A and mRNA stability factor HuR in human meningiomas. J Neurooncol 88:143-155
28. Wang H, Wang H, Zhang W, Fuller GN (2006) Overexpression of IGFBP5, but not IGFBP3, correlates with the histologic grade of human diffuse glioma: a tissue microarray and immunohistochemical study. Technol Cancer Res Treat 5:195-199 (Pubitemid 43946253)
29. Lehr HA, Mankoff DA, Corwin D, Santeusanio G, Gown A (1997) Application of Photoshop-based image analysis to quantification of hormone receptor expression in breast cancer. J Histochem Cytochem 45:1559-1565 (Pubitemid 27465476)
30. Meisner N-C, Hintersteiner M, Mueller K et al (2007) Identification and mechanistic characterization of low-molecular-weight inhibitors for HuR. Nat Chem Biol 3:508-515 (Pubitemid 47080371)
31. Mazroui R, Di Marco S, Clair E, von Roretz C, Tenenbaum SA, Keene JD, Saleh M, Gallouzi IE (2008) Caspase-mediated cleavage of HuR in the cytoplasm contributes to pp32/PHAP-I regulation of apoptosis. J Cell Biol 180:113-127
32. Hara A, Okayasu I (2004) Cyclooxygenase-2 and inducible nitric oxide synthase expression in human astrocytic gliomas: correlation with angiogenesis and prognostic significance. Acta Neuropathol 108:43-48 (Pubitemid 38961072)
33. Shono T, Tofilon PJ, Bruner JM, Owolabi O, Lang FF (2001) Cyclooxygenase-2 expression in human gliomas: prognostic significance and molecular correlations. Cancer Res 61:4375-4381 (Pubitemid 32685762)
34. Ma WJ, Cheng S, Campbell C, Wright A, Furneaux H (1996) Cloning and characterization of HuR, a ubiquitously expressed Elav-like protein. J Biol Chem 271:8144-8151 (Pubitemid 26108641)
35. Levy NS, Chung S, Furneaux H, Levy AP (1998) Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR. J Biol Chem 273:6417-6423 (Pubitemid 28144735)
36. Berkman RA, Merrill MJ, Reinhold WC et al (1993) Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms. J Clin Invest 91:153-159 (Pubitemid 23037267)
37. Orian JM, Vasilopoulos K, Yoshida S, Kaye AH, Chow CW, Gonzales MF (1992) Overexpression of multiple oncogenes related to histological grade of astrocytic glioma. Br J Cancer 66(1):106-112
38. Dixon DA, Tolley ND, King PH et al (2001) Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cells. J Clin Invest 108:1657-1665 (Pubitemid 33144876)
39. King PH (2000) RNA-binding analyses of HuC and HuD with the VEGF and c-myc 30-untranslated regions using a novel ELISAbased assay. Nucleic Acids Res 28:E20
40. Marderosian M, Sharma A, Funk AP et al (2006) Tristetraprolin regulates Cyclin D1 and c-Myc mRNA stability in response to rapamacycinin an Akt-dependent manner via p38 MAPK signaling. Oncogene 25:6277-6290 (Pubitemid 44564744)
41. L'Ecuyer TJ, Tompach PC, Morris E, Fulton AB (1995) Transdifferentiation of chicken embryonic cells into muscle cells by the 3′ untranslated region of muscle tropomyosin. Proc Natl Acad Sci USA 92:7520-7524
42. Suswam E, Li Y, Zhang X et al (2008) Tristetraprolin downregulates interleukin-8 and vascular endothelial growth factor in malignant glioma cells. Cancer Res 68:674-682 (Pubitemid 351206742)
43. Sabourin LA, Tamai K, Narang MA, Korneluk RG (1997) Overexpression of 30-untranslated region of the myotonic dystrophy kinase cDNA inhibits myoblast differentiation in vitro. J Biol Chem 272:29626-29635
44. Neve RL, Ivins KJ, Tsai KC, Rogers SL, Perrone-Bizzozero NI (1999) Cis-acting regulatory elements in the GAP-43 mRNA 3′-untranslated region can function in trans to suppress endogenous GAP-43 gene expression. Brain Res 65:52-60 (Pubitemid 29138678)
45. Mason CAE, Bigras J-L, O'Blenes SB et al (1999) Gene transfer in utero biologically engineers a patent ductus arteriosus in lambs by arresting fibronectin-dependent neointimal formation. Nat Med 5:176-182 (Pubitemid 29068524)
46. Mallon BS, Macklin WB (2002) Overexpression of the 3′-untranslated region of myelin proteolipid protein mRNA leads to reduced expression of endogenous proteolipid mRNA. Neurochem Res 27:1349-1360 (Pubitemid 36014148)
47. Storbeck CJ, Drmanic S, Daniel K et al (2004) Inhibition of myogenesis in transgenic mice expressing the human DMPK 3′-UTR. Hum Mol Genet 13:589-600 (Pubitemid 38379849)
48. Westmark PR, Shin HC, Westmark CJ, Soltaninassab SR, Reinke EK, Malter JS (2006) Decoy mRNAs reduce beta-amyloid precursor protein mRNA in neuronal cells. Neurobiol Aging 27:787-796
49. Shir A, Ogris M, Wagner E, Levitzki A (2006) EGF receptortargeted synthetic double-stranded RNA eliminates glioblastoma, breast cancer, and adenocarcinoma tumors in mice. PloS Med 3:e6